Placenta percreta management in a patient with a severe congenital hypofibrinogenemia

被引:0
作者
Wimmer, Jordan [1 ]
Sattler, Laurent [1 ]
Herb, Agathe [1 ]
Pontvianne, Mary [2 ]
Boudier, Eric [2 ]
Hengen, Maryse [3 ]
Thuet, Vincent [3 ]
Feugeas, Olivier [4 ]
Desprez, Dominique [4 ]
机构
[1] Hop Univ Strasbourg, Hop Hautepierre, Lab Hematol Biol, Ave Moliere, F-67000 Strasbourg, France
[2] Hop Univ Strasbourg, Serv Gynecol, Strasbourg, France
[3] Hop Univ Strasbourg, Serv Anesthesiol, Strasbourg, France
[4] Hop Univ Strasbourg, Ctr Competence Troubles Hemostase, Strasbourg, France
关键词
severe congenital hypofibrinogenemia; placenta percreta; post-partum hemorrhage; obstetric complications; platelet disorder with abnormal phospholipid externalization; FIBRINOGEN DISORDERS;
D O I
10.1684/abc.2023.1802
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The obstetrical follow-up of patients with a severe hypofibrin-ogenemia requires a multidisciplinary collaboration because of potential maternal-fetal complications (recurrent miscarriages, intrauterine fetal demise, post-partum hemorrhage, thrombosis). We report the obstetrical management of a multiparous patient with a severe congenital hypofi-brinogenemia associated with a platelet disorder (abnormal phospholipid externalization). A therapeutic strategy based on a biweekly administra-tion of fibrinogen concentrates associated with enoxaparin and aspirin allowed the maintenance of pregnancy. But this last one got complicated by a placenta percreta requiring a salvage hysterectomy with an appropri-ate hemorrhage prophylaxis.
引用
收藏
页码:210 / 216
页数:7
相关论文
共 14 条
[1]  
[Anonymous], 2018, J THROMB HAEMOST, V16, P1887
[2]   Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency [J].
Asselta, Rosanna ;
Plate, Manuela ;
Robusto, Michela ;
Borhany, Munira ;
Guella, Ilaria ;
Solda, Giulia ;
Afrasiabi, Abdolreza ;
Menegatti, Marzia ;
Shamsi, Tahir ;
Peyvandi, Flora ;
Duga, Stefano .
THROMBOSIS AND HAEMOSTASIS, 2015, 113 (03) :567-576
[3]   Can the phenotype of inherited fibrinogen disorders be predicted? [J].
Casini, A. ;
De Moerloose, P. .
HAEMOPHILIA, 2016, 22 (05) :667-675
[4]   Clinical Features and Management of Congenital Fibrinogen Deficiencies [J].
Casini, Alessandro ;
de Moerloose, Philippe ;
Neerman-Arbez, Marguerite .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (04) :366-374
[5]   Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases [J].
de Marcillac, F. Daney ;
Lecointre, L. ;
Guillaume, A. ;
Sananes, N. ;
Fritz, G. ;
Viville, B. ;
Boudier, E. ;
Nisand, I. ;
Gaudineau, A. ;
Langer, B. ;
Akladios, C. Y. .
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2016, 45 (08) :849-858
[6]   Congenital Fibrinogen Disorders: An Update [J].
de Moerloose, Philippe ;
Casini, Alessandro ;
Neerman-Arbez, Marguerite .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (06) :585-595
[7]   Pregnancy and rare bleeding disorders [J].
Kadir, R. ;
Chi, C. ;
Bolton-Maggs, P. .
HAEMOPHILIA, 2009, 15 (05) :990-1005
[8]  
Mackie IJ, 2002, THROMB HAEMOSTASIS, V87, P997
[9]   Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia [J].
Miesbach, W. ;
Schenk, J. ;
Alesci, S. ;
Lindhoff-Last, E. .
THROMBOSIS RESEARCH, 2010, 126 (06) :E428-E433
[10]   Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy [J].
Nurden, Paquita ;
Stritt, Simo ;
Favier, Remi ;
Nurden, Alan T. .
HAEMATOLOGICA, 2021, 106 (02) :337-350